Back to Search Start Over

The role of heparin bridging in lung cancer surgery: a nationwide database analysis.

Authors :
Mori, Masataka
Ibayashi, Koki
Kanayama, Masatoshi
Takenaka, Masaru
Kuroda, Koji
Muramatsu, Keiji
Fujino, Yoshihisa
Matsuda, Shinya
Tanaka, Fumihiro
Source :
Surgery Today; Jun2021, Vol. 51 Issue 6, p923-930, 8p
Publication Year :
2021

Abstract

Purpose: There is little evidence to demonstrate the impact of heparin bridging (HB) in major surgery. This study aimed to evaluate the benefits and risks of HB in lung cancer surgery by comparing HB and non-HB (NHB) groups. Methods: We extracted patients who were taking an anticoagulant, were diagnosed with lung cancer, and underwent lung resection between April 2014 and March 2018 from a nationwide database in Japan. We compared the HB and NHB groups to determine the benefits and risks of HB. The proportion of postoperative thromboembolism and bleeding events between the HB and NHB groups was the primary outcome. We performed propensity score matching to remove any HB assignment bias. Results: We selected 2416 patients, and among these, 1068 patients had HB and 1348 did not. Propensity score matching extracted 1500 patients: 750 with HB and 750 without HB. After matching, a Chi-square test showed no significant difference in the incidence of postoperative thromboembolism (1.5% vs 0.9%, p value = 0.343) and bleeding events (5.9% vs 4.0%, p value = 0.124) between the two groups. Conclusions: There was no significant difference in the incidence of postoperative thromboembolism and bleeding in the patients with and those without HB. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09411291
Volume :
51
Issue :
6
Database :
Complementary Index
Journal :
Surgery Today
Publication Type :
Academic Journal
Accession number :
150453128
Full Text :
https://doi.org/10.1007/s00595-020-02165-6